Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late-term clinical results

Ryan Brown, Marcus Williams, Colin Barker, Laura Mauri, Ian Meredith, Jean Fajadet, William Wijns, Martin Leon, David Kandzari

Research output: Contribution to journalArticleResearchpeer-review

14 Citations (Scopus)


OBJECTIVES: We examined angiographic and late-term clinical outcomes according to sex in recent percutaneous coronary intervention (PCI) trials involving zotarolimus-eluting stents (ZES). BACKGROUND: Differences in outcome between men and women undergoing PCI have been inconsistently described with bare metal and first-generation drug-eluting stents. METHODS: Clinical and angiographic outcomes among ZES-treated patients were evaluated by sex using propensity score modeling in a patient-level systematic overview of six trials and were also compared to patients receiving bare metal stents (BMS).
Original languageEnglish
Pages (from-to)804 - 813
Number of pages10
JournalCatheterization and Cardiovascular Interventions
Issue number6
Publication statusPublished - 2010

Cite this